Aptose Biosciences Inc. (NASDAQ: APTO)
$0.71
+0.0066 ( +0.94% ) 22.3K
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Market Data
Open
$0.71
Previous close
$0.70
Volume
22.3K
Market cap
$12.43M
Day range
$0.69 - $0.73
52 week range
$0.67 - $5.10
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
pre | Proxies and info statements | 13 | Jul 05, 2024 |
8-k | 8K-related | 15 | Jun 20, 2024 |
8-k | 8K-related | 14 | Jun 20, 2024 |
8-k | 8K-related | 15 | Jun 14, 2024 |
8-k | 8K-related | 22 | Jun 03, 2024 |
8-k | 8K-related | 15 | Jun 03, 2024 |
8-k | 8K-related | 15 | May 31, 2024 |
def | Proxies and info statements | 6 | May 15, 2024 |
10-q | Quarterly Reports | 65 | May 14, 2024 |
8-k | 8K-related | 15 | May 14, 2024 |